GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » HCmed Innovations Co Ltd (ROCO:6934) » Definitions » Cash Ratio

HCmed Innovations Co (ROCO:6934) Cash Ratio : 5.26 (As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is HCmed Innovations Co Cash Ratio?

The Cash Ratio measures a company’s ability to meet its short-term obligations with cash and near-cash resources. It is calculated as a company's Cash, Cash Equivalents, Marketable Securities divides by its Total Current Liabilities. HCmed Innovations Co's Cash Ratio for the quarter that ended in Jun. 2024 was 5.26.

HCmed Innovations Co has a Cash Ratio of 5.26. It generally indicates that the company is able to cover all short-term debt and still have cash remaining.

The historical rank and industry rank for HCmed Innovations Co's Cash Ratio or its related term are showing as below:

ROCO:6934' s Cash Ratio Range Over the Past 10 Years
Min: 2.21   Med: 5.26   Max: 6.1
Current: 5.26

During the past 3 years, HCmed Innovations Co's highest Cash Ratio was 6.10. The lowest was 2.21. And the median was 5.26.

ROCO:6934's Cash Ratio is ranked better than
86.15% of 859 companies
in the Medical Devices & Instruments industry
Industry Median: 1.09 vs ROCO:6934: 5.26

HCmed Innovations Co Cash Ratio Historical Data

The historical data trend for HCmed Innovations Co's Cash Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HCmed Innovations Co Cash Ratio Chart

HCmed Innovations Co Annual Data
Trend Dec21 Dec22 Dec23
Cash Ratio
2.47 6.10 6.00

HCmed Innovations Co Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Cash Ratio Get a 7-Day Free Trial - 6.10 2.21 6.00 5.26

Competitive Comparison of HCmed Innovations Co's Cash Ratio

For the Medical Devices subindustry, HCmed Innovations Co's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HCmed Innovations Co's Cash Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, HCmed Innovations Co's Cash Ratio distribution charts can be found below:

* The bar in red indicates where HCmed Innovations Co's Cash Ratio falls into.



HCmed Innovations Co Cash Ratio Calculation

The Cash Ratio measures a company's ability to meet its short-term obligations with its cash and near-cash resources.

HCmed Innovations Co's Cash Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash Ratio (A: Dec. 2023 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=243.614/40.583
=6.00

HCmed Innovations Co's Cash Ratio for the quarter that ended in Jun. 2024 is calculated as:

Cash Ratio (Q: Jun. 2024 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=170.478/32.406
=5.26

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


HCmed Innovations Co  (ROCO:6934) Cash Ratio Explanation

The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.

The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.

In general, the higher the cash ratio, the better the company's liquidity position.


HCmed Innovations Co Cash Ratio Related Terms

Thank you for viewing the detailed overview of HCmed Innovations Co's Cash Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


HCmed Innovations Co Business Description

Traded in Other Exchanges
N/A
Address
Dunhua S. Road, Rm.B, 10th floor., No.319, Sec.2, Taipei, TWN, 106033
HCmed Innovations Co Ltd is focused on inhalation therapy to create integrated drug nebulizer combination products featuring nebulization therapeutic drugs that include small molecule synthetics and large molecule biologics, as either solutions, suspensions, and even difficult-to-deliver high viscosity drugs. Its product include Pulmogine and AdheResp.

HCmed Innovations Co Headlines

No Headlines